Company Name
Sichuan Elixir Pharmaceutical Co., Ltd.
Year of Establishment
2021
Company Introduction
Focus on natural origin and oncology APIs, setting up R&D and production platform for new salt and crystal form, deep cooperation with clients for IND, NDA, ANDA, 505b(2) or P-IV challenge.
Explore the potential of macromolecular APIs, setting up R&D and production platform for Glycans and polypeptide.
Specialized in XDC drugs field, committed to platform building for the innovative research and production on payload and Best-Link.
Global registration platform, professional team, and international cGMP system.
API CDMO service with global registration.
Strategy: FDF + APIs.
Tel: +86-28-17360040767
Website: www.xielipharm.com.cn、www.elixir-pharm.com
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Small Orders Accepted,Quality Service,
Other Competitive Advantages
R&D Team
(1)Stable R&D team with over 10 years of experience, more than 20 successful R&D projects.
(2)Synthesis Lab with GRLP standard.
(3)Analysis Lab in accordance with GMP conditions.
(4)In collaboration with well-known universities, focus on new salt, new crystal form and novel technologies, such as synthetic biology and continuous-flow synthetic.